Fidelis Capital Partners, LLC Twist Bioscience Corp Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 399 shares of TWST stock, worth $21,506. This represents 0.05% of its overall portfolio holdings.
Number of Shares
399Holding current value
$21,506% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding TWST
# of Institutions
253Shares Held
65.6MCall Options Held
247KPut Options Held
203K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.94MShares$374 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.77MShares$311 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$294 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.64MShares$250 Million0.25% of portfolio
-
Jpmorgan Chase & CO New York, NY3.61MShares$195 Million0.01% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $3.04B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...